Worldwide Clinical Trials Launches Large Molecule Services

Article

Worldwide Clinical Trials, Inc. has announced the extension of its service offerings to include large molecule capabilities, now integrated into its preexisting clinical pharmacology and pharmacokinetics business unit. Capabilities include pharmacodynamic studies, pharmacokinetics, biomarker assays, and immunogenicity testing.

Read more about the new service offerings here.

Related Videos
Greg Ball, Founder, ASAP Process Consulting image credit screen shot from video
Janice Chang, CEO, TransCelerate BioPharma @ video screenshot.
Applied Clinical Trials and LabConnect
Cat Hall endpoint Clinical
OM1 Sonja Wustrack
© 2023 MJH Life Sciences

All rights reserved.